Manual práctico de Trombosis y Hemostasia de la SETH

— 1 7 3 — 1 3 . S í n d r o m e a n t i f o s f o l i p í d i c o 8. Devreese KM, Pierangeli SS, de Laat B, Tripodi A, Atsumi T, Ortel TL, Subcommittee on Lupus Anticoagulant/Phospholipid/ Dependent A. Testing for antiphospholipid antibodies with solid phase assays: guidance from the SSC of the ISTH. J Thromb H J Thromb Haemost 2014;12:792-5. 9. De Laat B, Pengo V, Pabinger I, Musial J, Voskuyl AE, Bultink IE, et al. The associationbetween circulating antibodies against do- main I of beta2-glycoprotein I and thrombosis: an international multicenter study. J Thromb Haemost 2009;7:1767-73. 10. Espinosa G, Cervera R. Current treatment of antiphospholipid syndrome: lights and shadows. Nat Rev Rheumatol 2015;11: 586-96. 11. Sciascia S, Khamashta MA, D’Cruz DP. Targeted therapy in anti- phospholipid syndrome. Curr Opin Rheumatol 2014;26:269-75. 12. Nalli C, Andreoli L, Casu C,Tincani A. Management of recurrent thrombosis in antiphospholipid syndrome. Curr Rheumatol Rep 2014;16:405. 13. Sciascia S, Amigo MC, Roccatello D, Khamashta M. Diagnosing antiphospholipid syndrome: ‘extra-criteria’ manifestations and te- chnical advances. Nat Rev Rheumatol 2017;13:548-60. 14. Sciascia S, Sanna G, Murru V, Roccatello D, Khamashta MA, Bertolaccini ML.The global anti-phospholipid syndrome score in primary APS. Rheumatology (Oxford) 2015;54:134-8. 15. Sciascia S, Branch DW, Levy RA, Middeldorp S, Pavord S, Roccatello D, et al.The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies. Evidence and clinical judgment. Thromb Haemost 2016;115: 285-90.